Credit Suisse Downgrades McKesson (MCK) to Underperform
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Credit Suisse downgraded McKesson (NYSE: MCK) from Neutral to Underperform with a price target of $131.00 (from $150.00) on capital efficiency discrepancy.
Analyst Robert Willoughby commented, "MCK pointed to irrational industry pricing for a second negative EPS revision this year. AmerisourceBergen and Cardinal Health also noted weaker pricing, but with competitive advantages in generic sourcing capabilities from an invested capital standpoint, their practices seem more consistent with maintaining high ROICs. MCK's average invested capital base equals the sum for its two competitors, yet its NOPAT grew at about half the CAGR over FY12-FY16, with higher capital requirements and lower earnings ahead, in our view. Longer term, it may benefit more from owning sourcing capabilities outright, but Celesio contributions, higher deal spend/capital needs, and distortions from the pending Technology Solutions exit limit our near term enthusiasm."
Shares of McKesson closed at $141.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Upgrades Essex Property Trust (ESS) to Overweight
- Expect Twilio (TWLO) To Exceed Baseline Revenue Estimates, 2017 Guidance Likely Conservative - William Blair
- Union Pacific (UNP) PT Raised to $102 at Stifel Following 4Q Report
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Downgrades, Hot Downgrades
Related EntitiesCredit Suisse, Earnings, Robert Willoughby
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!